CAS: 129580-63-8 - Satraplatin

Formula: C₁₀H₂₂Cl₂N₂O₄Pt

InChI: InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4

InChI key: InChIKey=CKNPWBAXEKSCRG-UHFFFAOYSA-J

SMILES: O=C([O-][Pt+4]([Cl-])([Cl-])([O-]C(=O)C)([NH3])[NH2]C1CCCCC1)C

Synonyms:

• Bis(acetato-O)amminedichloro(cyclohexanamine)-pt
• Bms 182751
• Bmy 45594
• Cyclohexanamine, platinum complex
• Jm 216
• POplat
• Platinum (lV) cis-dichloro-trans-bis(acetato-O)ammine(cyclohexanamine)
• Platinum(4+) Chloride Acetate Cyclohexanamine Ammoniate (1:2:2:1:1)
• Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)-
• Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)-
• Satraplatin

Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)- (9CI)

CAS: 129580-63-8

• Formula: C₁₀H₂₄Cl₂N₂O₄Pt
• Purity: 98%
• Molecular weight: 502.2926

Satraplatin

CAS: 129580-63-8

• Formula: C₁₀H₂₂Cl₂N₂O₄Pt
• Purity: ≥ 98.0%
• Color and Shape: White to light yellow powder
• Molecular weight: 500.28

Satraplatin

CAS: 129580-63-8

Satraplatin (BMS182751) is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and …

• Formula: C₁₀H₂₂Cl₂N₂O₄Pt
• Purity: ≥95%
• Color and Shape: Solid
• Molecular weight: 500.28

Satraplatin

CAS: 129580-63-8

Platinum-based chemotherapeutic agent

• Formula: C₁₀H₂₂Cl₂N₂O₄Pt
• Purity: Min. 95%
• Color and Shape: Slightly Yellow Powder
• Molecular weight: 500.28 g/mol